South Korea Diagnostic Labs Market Research Report: Forecast (2026-2032)

South Korea Diagnostic Labs Market - By Test Type (Pathology, Radiology & Imaging), By Pathology Test Type (Clinical Chemistry, Hematology, Immunology & Serology, Microbiology, Histopathology & Cytopa... ... topathology & Cytopathology, Molecular Diagnostics, Genetic Testing), By Radiology Type (X-Ray, Ultrasound, CT Scan, MRI, Mammography, PET-CT, Nuclear Imaging, Others), By Service Delivery Mode (Walk-in Testing, Home Sample Collection, Mobile Diagnostic Units), By Disease Type (Infectious Diseases, Oncology, Diabetes & Endocrinology, Cardiology, Neurology, Nephrology, Gastroenterology, Gynecology & Obstetrics, Respiratory Disorders, Orthopedics, Others), By End-User (Hospitals, Physician Clinics, Independent Diagnostic Centers, Corporate & Preventive Health Programs, Government & Public Healthcare Institutions), and others Read more

  • Healthcare
  • Feb 2026
  • 135
  • PDF, Excel, PPT

South Korea Diagnostic Labs Market Report Key Takeaways:

  • Market size was valued at around USD1.06 billion in 2025 and is projected to reach USD1.81 billion by 2032. The estimated CAGR from 2026 to 2032 is around 7.45%, indicating strong growth.
  • By Radiology Type, the X-Ray Testing segment represented a significant share of about 34% in the South Korea Diagnostic Labs Market in 2025.
  • By End-User, the Hospitals seized a significant share of about 75% in the South Korea Diagnostic Labs Market in 2025.
  • Leading Diagnostic Labs Companies in the South Korea Market are GC Labs, Seoul Clinical Laboratories, Seegene Medical Foundation, MEDICHECK Lab, GCCL Co., Ltd., EONE Laboratories, SCL Healthcare, Samkwang Medical Lab, CHA BIOTECH, SNU Boramae Medical Center Clinical Lab, and Others.

Market Insights & Analysis: South Korea Diagnostic Labs Market (2026-32):

The Diagnostic Labs Market size was valued at approximately USD1.06 billion in 2025 and is projected to reach USD1.81 billion by 2032. Along with this, the market is estimated to grow at a CAGR of around 7.45% during the forecast period, i.e., 2026-32.

The market operates within a highly regulated universal healthcare system driven by rapid technology adoption and strong public–private collaboration. According to the Ministry of Health and Welfare of South Korea, diagnostic imaging volumes rose steadily over the past few years. Additionally, South Korea’s aging population, with over 20% aged above 65 in 2024, continues to structurally increase diagnostic demand.

Additionally, market dynamics are shaped by high imaging utilization, early disease detection policies, and government-backed digital healthcare expansion. According to the National Health Insurance Service, radiology-linked diagnostics account for a substantial share of reimbursed outpatient services. Likewise, cancer screening mandates for breast, lung, colorectal, and liver cancers significantly elevate imaging frequency. Technological intensity remains high, with South Korea ranking among the top OECD countries for MRI and CT scanners per million individuals.

Moreover, manufacturing and infrastructure investments further reinforce market growth. For instance, in November 2025, the Republic of Korea government, including the Ministry of Trade, Industry and Energy, approved an advanced medical device R&D program worth about USD645 million over seven years to develop next-generation medical devices with a focus on AI diagnostics and high-tech solutions , targeting domestic supply chain resilience. Similarly, leading hospital networks expanded radiology wings and AI-enabled diagnostic centers in Seoul, Busan, and Gyeonggi Province. Greenfield expansions by private diagnostic chains focused on high-throughput imaging hubs integrated with laboratory information systems.

South Korea Diagnostic Labs Market Recent Developments:

  • 2025 : Seoul Clinical Laboratories maintained its leadership in reference lab services, holding updated diagnostic test certifications through health authorities, and continued support for clinical trials via its central lab (C-LAB) operations.
  • 2026 : GCCL announced a strategic collaboration with OPIS to advance global clinical trial lab capabilities, integrating central lab services and expanding multinational trial support.

South Korea Diagnostic Labs Market Scope:

 Category  Segments
By Test Type Pathology, Radiology & Imaging
By Pathology Test Type Clinical Chemistry, Hematology, Immunology & Serology, Microbiology, Histopathology & Cytopathology, Molecular Diagnostics, Genetic Testing
By Radiology Type X-Ray, Ultrasound, CT Scan, MRI, Mammography, PET-CT, Nuclear Imaging, Others
By Service Delivery Mode Walk-in Testing, Home Sample Collection, Mobile Diagnostic Units
By Disease Type Infectious Diseases, Oncology, Diabetes & Endocrinology, Cardiology, Neurology, Nephrology, Gastroenterology, Gynecology & Obstetrics, Respiratory Disorders, Orthopedics, Others
By End-User Hospitals, Physician Clinics, Independent Diagnostic Centers, Corporate & Preventive Health Programs, Government & Public Healthcare Institutions

South Korea Diagnostic Labs Market Driver:

High Burden of Chronic Diseases

The rising prevalence of chronic diseases is a major driver of the South Korea diagnostic labs market, as long-term disease management depends heavily on frequent laboratory and imaging tests. According to the Korea Disease Control and Prevention Agency (KDCA), non-communicable diseases account for over 80% of total deaths in South Korea, with cancer, cardiovascular diseases, diabetes, and chronic respiratory conditions being the leading contributors. These conditions require continuous monitoring through pathology tests and diagnostic imaging.

Cancer remains the most significant disease burden. According to the National Cancer Center Korea, more than 280,000 new cancer cases are diagnosed annually, and the five-year cancer prevalence exceeded 2.3 million patients in recent years. Cancer diagnosis, staging, and post-treatment surveillance rely heavily on repeated imaging (CT, MRI, PET-CT) and laboratory testing, directly increasing diagnostic lab utilization across hospital and independent lab settings.

Chronic metabolic diseases further intensify diagnostic demand. According to the Korean Diabetes Association, approximately 16% of adults aged 30 and above have diabetes, while an additional 30% are classified as pre-diabetic . These patients require routine blood glucose, HbA1c, lipid profile, kidney function, and cardiovascular risk testing, ensuring recurring test volumes for diagnostic laboratories.

  1. Market Segmentation
  2. Introduction
    1. Product Definition
    2. Research Process
    3. Assumptions
  3. Executive Summary
  4. South Korea Diagnostic Labs Market Policies, Regulations, and Product Standards
  5. South Korea Diagnostic Labs Market Trends & Developments
  6. South Korea Diagnostic Labs Market Dynamics
    1. Growth Factors
    2. Challenges
  7. South Korea Diagnostic Labs Market Hotspot & Opportunities
  8. South Korea Diagnostic Labs Market Outlook, 2022-2032F
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Test Type- Market Size & Forecast 2022-2032, USD Million
        1. Pathology
        2. Radiology & Imaging
      2. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
        1. Clinical Chemistry
        2. Hematology
        3. Immunology & Serology
        4. Microbiology
        5. Histopathology & Cytopathology
        6. Molecular Diagnostics
        7. Genetic Testing
      3. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
        1. X-Ray
        2. Ultrasound
        3. CT Scan
        4. MRI
        5. Mammography
        6. PET-CT
        7. Nuclear Imaging
        8. Others 
      4. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
        1. Walk-in Testing
        2. Home Sample Collection
        3. Mobile Diagnostic Units
      5. By Disease Type - Market Size & Forecast 2022-2032, USD Million
        1. Infectious Diseases
        2. Oncology
        3. Diabetes & Endocrinology
        4. Cardiology
        5. Neurology
        6. Nephrology
        7. Gastroenterology
        8. Gynecology & Obstetrics
        9. Respiratory Disorders
        10. Orthopedics
        11. Others
      6. By End-User- Market Size & Forecast 2022-2032, USD Million
        1. Hospitals
        2. Physician Clinics
        3. Independent Diagnostic Centers
        4. Corporate & Preventive Health Programs
        5. Government & Public Healthcare Institutions
      7. By Region- Market Size & Forecast 2022-2032, USD Million
        1. Seoul
        2. Busan
        3. Central
        4. Gyeonggi
        5. Cheongju
      8. By Company
        1. Competition Characteristics
        2. Market Share & Analysis
  9. South Korea Pathology Labs Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
      2. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
      3. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
      4. By Disease Type - Market Size & Forecast 2022-2032, USD Million
      5. By End-User- Market Size & Forecast 2022-2032, USD Million
      6. By Region- Market Size & Forecast 2022-2032, USD Million
  10. South Korea Radiology & Imaging Labs Market Outlook, 2022-2032
    1. Market Size & Outlook
      1. By Revenues (USD Million)
    2. Market Share & Outlook
      1. By Pathology Test Type- Market Size & Forecast 2022-2032, USD Million
      2. By Radiology Type- Market Size & Forecast 2022-2032, USD Million
      3. By Service Delivery Mode- Market Size & Forecast 2022-2032, USD Million
      4. By Disease Type - Market Size & Forecast 2022-2032, USD Million
      5. By End-User- Market Size & Forecast 2022-2032, USD Million
      6. By Region- Market Size & Forecast 2022-2032, USD Million
  11. South Korea Diagnostic Labs Market Key Strategic Imperatives for Success & Growth
  12. Competitive Outlook
    1. Company Profiles
      1. GC Labs
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Seoul Clinical Laboratories
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Seegene Medical Foundation
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. MEDICHECK Lab
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. GCCL Co., Ltd.
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. EONE Laboratories
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. SCL Healthcare
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Samkwang Medical Lab
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. CHA BIOTECH
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. SNU Boramae Medical Center Clinical Lab
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
  13. Disclaimer


MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

Data Trangulation

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

We’d love to understand what matters most to you.

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .